Health

Results: 1561-1572 of 9208

PR Newswire associated0

First Patient Treated in Myra Vision's U.S. ADAPT Clinical Study for Glaucoma

Richter Extends Its Support to Africa - The First Year of the House of Hope in Bamako in Numbers

Novaliq Receives FDA IND Clearance to Advance NOV05 in a Phase II Clinical Trial in Non-infectious Anterior Uveitis

AesyBite Custom smart nightguard by Aesyra SA.

Aesyra Demonstrates Significant Sleep Bruxism Reduction in Clinical Study

Merz Therapeutics Submits Application to the European Medicines Agency for New Indication of XEOMIN® in Pediatric Spasticity

Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results

PA Media Assignments associated0

The Grassroots Grub Gap: New Campaign Launches To Support Uk Grassroots Football In Fueling Future Talent

Leqembi® Iqlik™ (lecanemab-irmb) supplemental Biologics License Application regarding subcutaneous starting dose granted Priority Review by the US FDA

Government to end cancer postcode lottery for patients

Philip Morris International Urges FDA Advisory Committee to Recommend Authorizing ZYN as a Modified Risk Tobacco Product

Dr Stuart Griffiths, Director of Research, Policy and Impact at Yorkshire Cancer Research.

Yorkshire Cancer Research statement on the Government’s National Cancer Plan: A major opportunity to end regional inequalities

ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer